AGP Picks
View all

Reusable gastroenterology endoscope market seen reaching $22.21 billion by 2030

Sep. 22, 2026
By AI, Created 16:30 UTC, Sep 22, 2026, AGP -

The reusable gastroenterology endoscope market is projected to grow from $13.27 billion in 2025 to $22.21 billion by 2030, driven by rising gastrointestinal disease burden and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth through the forecast period.

Why it matters: - The market is expanding as hospitals and ambulatory centers lean more heavily on endoscopy for diagnosis, screening, tissue sampling and treatment. - Growth reflects a larger global burden of gastrointestinal disorders, including colorectal cancer and chronic digestive disease. - The shift toward less invasive care is increasing demand for reusable devices that support repeated procedures and sterilization.

What happened: - The Business Research Company said the reusable gastroenterology endoscope market will rise from $13.27 billion in 2025 to $14.76 billion in 2026. - The report projects the market will reach $22.21 billion by 2030. - The forecast implies a 10.8% compound annual growth rate through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Reusable gastroenterology endoscopes are flexible medical devices used repeatedly to diagnose and treat conditions affecting the esophagus, stomach, intestines and colon. - The devices are cleaned and sterilized after each use and include imaging and light sources for internal examination and therapy. - The market’s recent growth is linked to more gastrointestinal disorders, higher volumes of endoscopic diagnostic procedures, expansion of hospital endoscopy units, better awareness of early disease detection and wider adoption of minimally invasive treatment. - Forecast growth is tied to advances in imaging, stronger demand for therapeutic gastrointestinal procedures, higher healthcare spending on endoscopy equipment, growth in ambulatory surgical centers and tighter infection control and reprocessing standards. - Expected product trends include more high-definition imaging endoscopes, greater preference for reusable devices with enhanced sterilization, expansion of therapeutic procedures and wider use of ultra-slim endoscopes. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company added market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables to its 2026 reports.

Between the lines: - The market forecast points to a steady upgrade cycle, not just unit growth, as providers seek better imaging, safer reprocessing and more therapeutic capability. - The regional outlook suggests mature demand in North America and faster infrastructure buildout in Asia-Pacific. - Colorectal cancer pressure remains a major demand driver; the American Cancer Society said in January 2024 that colorectal cancer is the second leading cause of cancer deaths in the U.S., with 53,010 estimated deaths in 2024. - The rising use of minimally invasive procedures supports endoscope demand; the American Society of Plastic Surgeons reported 7% growth in minimally invasive procedures in 2023 versus 2% growth for surgical procedures overall.

What's next: - Healthcare providers are likely to keep investing in endoscopy equipment as procedure volumes rise and infection-control expectations tighten. - Product development will likely focus on imaging quality, sterilization performance and patient comfort. - Demand should continue to track gastrointestinal disease prevalence and the spread of minimally invasive care across more settings.

The bottom line: - Reusable gastroenterology endoscopes are set for sustained growth through 2030 as providers balance diagnostic demand, therapeutic expansion and reprocessing requirements.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

LATAM Food & Beverage Industry Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM Food & Beverage Industry Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.